The scaffold protein IQGAP1 regulates cell signaling through the RAF/MEK/ERK 
pathway. Recent data show that cancer cells in which the RAF/MEK/ERK pathway is 
activated are particularly sensitive to the disruption of IQGAP1 function. IQGAP 
drugs may be particularly effective in tumors that develop resistance to 
existing pathway drugs.